Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats

Abstract Objective The aim of present study was to test the hypothesis that activation of receptor for advanced glycation end products (RAGE) pathway contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated (SAD) rats. Methods and results Experiment 1 : 8 weeks after sin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2013-08, Vol.229 (2), p.287-294
Hauptverfasser: Wu, Feng, Feng, Jin-Zhong, Qiu, Yi-Hua, Yu, Feng-Bin, Zhang, Jian-Zhong, Zhou, Wei, Yu, Feng, Wang, Guo-Kun, An, Li-Na, Ni, Fei-Hua, Wu, Hong, Zhao, Xian-Xian, Qin, Yong-Wen, Luo, He-De
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 294
container_issue 2
container_start_page 287
container_title Atherosclerosis
container_volume 229
creator Wu, Feng
Feng, Jin-Zhong
Qiu, Yi-Hua
Yu, Feng-Bin
Zhang, Jian-Zhong
Zhou, Wei
Yu, Feng
Wang, Guo-Kun
An, Li-Na
Ni, Fei-Hua
Wu, Hong
Zhao, Xian-Xian
Qin, Yong-Wen
Luo, He-De
description Abstract Objective The aim of present study was to test the hypothesis that activation of receptor for advanced glycation end products (RAGE) pathway contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated (SAD) rats. Methods and results Experiment 1 : 8 weeks after sinoaortic denervation, aortas were removed for measurement of AGE/RAGE pathway. Sinoaortic denervation in rats resulted in enhanced activity of aldose reductase, reduced activity of glyoxalase 1, accumulation of methylglyoxal and AGE, and upregulated expression of RAGE in aortas. Experiment 2 : 5 weeks after sinoaortic denervation, the rats received intraperitoneal injections of 500 μg soluble RAGE (sRAGE) daily for 3 weeks. Treatment of SAD rats with sRAGE attenuated aortic remodeling, marked by reduction in AW/length, wall thickness, proliferation of SMC, and collagen deposition, and improvement of endothelial function. Treatment of SAD rats with sRAGE abated aortic oxidative stress, marked by reduction in formation of malondialdehyde, reactive oxygen species, superoxide, peroxynitrite and 3-nitrotyrosine, and enhancement of ratio of GSH/GSSG. Treatment of SAD rats with sRAGE attenuated aortic mitochondrial dysfunction. Treatment of SAD rats with sRAGE suppressed aortic NFκB nuclear translocation and inflammation. Treatment of SAD rats with sRAGE restored aortic NO formation through upregulating eNOS and dimethylarginine dimethylaminohydrolase-2 and downregulating protein arginine methyltransferase-1. Conclusion Activated RAGE contributed to aortic remodeling and endothelial dysfunction in SAD rats, possibly via induction of oxidative stress and inflammation, impairment of mitochondrial function, and reduction in NO bioavailability.
doi_str_mv 10.1016/j.atherosclerosis.2013.04.033
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1412558515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S002191501300275X</els_id><sourcerecordid>1412558515</sourcerecordid><originalsourceid>FETCH-LOGICAL-c589t-fe3bb4168e30b7386812db23fa311170ab661d9da83a4e6a21259dbd5a5f8b9e3</originalsourceid><addsrcrecordid>eNqNks2O0zAUhSMEYsrAK4A3SGxSfOP8OAuQRiMYkEZiMYzEznLsm-KS2sV2KvVBeF9uaGExKxb-WZxz7vX9XBSvga-BQ_t2u9b5O8aQzLTsLq0rDmLN6zUX4lGxAtn1JdSyflysOK-g7KHhF8WzlLac87oD-bS4qISUHDq5Kn5dmewOOrvgWRhZRIP7HCIbaWl70N6gZZvpaE4S9JbtY7CzyYmZ4HN0w5wxsRyYDjE7QxG7YHFyfsM0qckRqOHJ6YnZYxpnb_4kOc-S8-FssugxUhtULOqcnhdPRj0lfHE-L4v7jx--Xn8qb7_cfL6-ui1NI_tcjiiGoYZWouBDJ2QrobJDJUYtAKDjemhbsL3VUugaW11B1fR2sI1uRjn0KC6LN6dcetPPGVNWO5cMTpP2GOakoCZHIxtoSPruJDU09RRxVPvodjoeFXC1kFFb9YCMWsgoXisiQ_6X51LzsEP7z_0XBQlenQSjDkpvIvnv7yihWbD10HWkuDkpkEZycBhVMg4XQo64ZWWD--9m3j9IMgTMGT39wCOmbZijp7krUKlSXN0tH2n5RyDo1jXfxG_GJcws</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1412558515</pqid></control><display><type>article</type><title>Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wu, Feng ; Feng, Jin-Zhong ; Qiu, Yi-Hua ; Yu, Feng-Bin ; Zhang, Jian-Zhong ; Zhou, Wei ; Yu, Feng ; Wang, Guo-Kun ; An, Li-Na ; Ni, Fei-Hua ; Wu, Hong ; Zhao, Xian-Xian ; Qin, Yong-Wen ; Luo, He-De</creator><creatorcontrib>Wu, Feng ; Feng, Jin-Zhong ; Qiu, Yi-Hua ; Yu, Feng-Bin ; Zhang, Jian-Zhong ; Zhou, Wei ; Yu, Feng ; Wang, Guo-Kun ; An, Li-Na ; Ni, Fei-Hua ; Wu, Hong ; Zhao, Xian-Xian ; Qin, Yong-Wen ; Luo, He-De</creatorcontrib><description>Abstract Objective The aim of present study was to test the hypothesis that activation of receptor for advanced glycation end products (RAGE) pathway contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated (SAD) rats. Methods and results Experiment 1 : 8 weeks after sinoaortic denervation, aortas were removed for measurement of AGE/RAGE pathway. Sinoaortic denervation in rats resulted in enhanced activity of aldose reductase, reduced activity of glyoxalase 1, accumulation of methylglyoxal and AGE, and upregulated expression of RAGE in aortas. Experiment 2 : 5 weeks after sinoaortic denervation, the rats received intraperitoneal injections of 500 μg soluble RAGE (sRAGE) daily for 3 weeks. Treatment of SAD rats with sRAGE attenuated aortic remodeling, marked by reduction in AW/length, wall thickness, proliferation of SMC, and collagen deposition, and improvement of endothelial function. Treatment of SAD rats with sRAGE abated aortic oxidative stress, marked by reduction in formation of malondialdehyde, reactive oxygen species, superoxide, peroxynitrite and 3-nitrotyrosine, and enhancement of ratio of GSH/GSSG. Treatment of SAD rats with sRAGE attenuated aortic mitochondrial dysfunction. Treatment of SAD rats with sRAGE suppressed aortic NFκB nuclear translocation and inflammation. Treatment of SAD rats with sRAGE restored aortic NO formation through upregulating eNOS and dimethylarginine dimethylaminohydrolase-2 and downregulating protein arginine methyltransferase-1. Conclusion Activated RAGE contributed to aortic remodeling and endothelial dysfunction in SAD rats, possibly via induction of oxidative stress and inflammation, impairment of mitochondrial function, and reduction in NO bioavailability.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2013.04.033</identifier><identifier>PMID: 23880178</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>advanced glycation end products ; aldehyde reductase ; Aldehyde Reductase - metabolism ; Animals ; Aorta - innervation ; Aorta - metabolism ; Aorta - physiopathology ; Aortic remodeling ; arginine ; atherosclerosis ; Autonomic Denervation ; Baroreflex - physiology ; bioavailability ; Cardiovascular ; Cardiovascular Diseases - metabolism ; Cardiovascular Diseases - physiopathology ; collagen ; Disease Models, Animal ; Endothelial dysfunction ; endothelial nitric oxide synthase ; Endothelium, Vascular - innervation ; Endothelium, Vascular - metabolism ; Endothelium, Vascular - physiopathology ; Inflammation ; Lactoylglutathione Lyase - metabolism ; Male ; malondialdehyde ; Mitochondria - metabolism ; Nitric oxide ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - metabolism ; Oxidative stress ; Oxidative Stress - physiology ; Rats ; Rats, Sprague-Dawley ; reactive oxygen species ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic - metabolism ; Sinoaortic denervation ; Vasculitis - metabolism ; Vasculitis - physiopathology</subject><ispartof>Atherosclerosis, 2013-08, Vol.229 (2), p.287-294</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2013 Elsevier Ireland Ltd</rights><rights>Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c589t-fe3bb4168e30b7386812db23fa311170ab661d9da83a4e6a21259dbd5a5f8b9e3</citedby><cites>FETCH-LOGICAL-c589t-fe3bb4168e30b7386812db23fa311170ab661d9da83a4e6a21259dbd5a5f8b9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S002191501300275X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23880178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Feng</creatorcontrib><creatorcontrib>Feng, Jin-Zhong</creatorcontrib><creatorcontrib>Qiu, Yi-Hua</creatorcontrib><creatorcontrib>Yu, Feng-Bin</creatorcontrib><creatorcontrib>Zhang, Jian-Zhong</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Yu, Feng</creatorcontrib><creatorcontrib>Wang, Guo-Kun</creatorcontrib><creatorcontrib>An, Li-Na</creatorcontrib><creatorcontrib>Ni, Fei-Hua</creatorcontrib><creatorcontrib>Wu, Hong</creatorcontrib><creatorcontrib>Zhao, Xian-Xian</creatorcontrib><creatorcontrib>Qin, Yong-Wen</creatorcontrib><creatorcontrib>Luo, He-De</creatorcontrib><title>Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Abstract Objective The aim of present study was to test the hypothesis that activation of receptor for advanced glycation end products (RAGE) pathway contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated (SAD) rats. Methods and results Experiment 1 : 8 weeks after sinoaortic denervation, aortas were removed for measurement of AGE/RAGE pathway. Sinoaortic denervation in rats resulted in enhanced activity of aldose reductase, reduced activity of glyoxalase 1, accumulation of methylglyoxal and AGE, and upregulated expression of RAGE in aortas. Experiment 2 : 5 weeks after sinoaortic denervation, the rats received intraperitoneal injections of 500 μg soluble RAGE (sRAGE) daily for 3 weeks. Treatment of SAD rats with sRAGE attenuated aortic remodeling, marked by reduction in AW/length, wall thickness, proliferation of SMC, and collagen deposition, and improvement of endothelial function. Treatment of SAD rats with sRAGE abated aortic oxidative stress, marked by reduction in formation of malondialdehyde, reactive oxygen species, superoxide, peroxynitrite and 3-nitrotyrosine, and enhancement of ratio of GSH/GSSG. Treatment of SAD rats with sRAGE attenuated aortic mitochondrial dysfunction. Treatment of SAD rats with sRAGE suppressed aortic NFκB nuclear translocation and inflammation. Treatment of SAD rats with sRAGE restored aortic NO formation through upregulating eNOS and dimethylarginine dimethylaminohydrolase-2 and downregulating protein arginine methyltransferase-1. Conclusion Activated RAGE contributed to aortic remodeling and endothelial dysfunction in SAD rats, possibly via induction of oxidative stress and inflammation, impairment of mitochondrial function, and reduction in NO bioavailability.</description><subject>advanced glycation end products</subject><subject>aldehyde reductase</subject><subject>Aldehyde Reductase - metabolism</subject><subject>Animals</subject><subject>Aorta - innervation</subject><subject>Aorta - metabolism</subject><subject>Aorta - physiopathology</subject><subject>Aortic remodeling</subject><subject>arginine</subject><subject>atherosclerosis</subject><subject>Autonomic Denervation</subject><subject>Baroreflex - physiology</subject><subject>bioavailability</subject><subject>Cardiovascular</subject><subject>Cardiovascular Diseases - metabolism</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>collagen</subject><subject>Disease Models, Animal</subject><subject>Endothelial dysfunction</subject><subject>endothelial nitric oxide synthase</subject><subject>Endothelium, Vascular - innervation</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Inflammation</subject><subject>Lactoylglutathione Lyase - metabolism</subject><subject>Male</subject><subject>malondialdehyde</subject><subject>Mitochondria - metabolism</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>reactive oxygen species</subject><subject>Receptor for Advanced Glycation End Products</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Sinoaortic denervation</subject><subject>Vasculitis - metabolism</subject><subject>Vasculitis - physiopathology</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks2O0zAUhSMEYsrAK4A3SGxSfOP8OAuQRiMYkEZiMYzEznLsm-KS2sV2KvVBeF9uaGExKxb-WZxz7vX9XBSvga-BQ_t2u9b5O8aQzLTsLq0rDmLN6zUX4lGxAtn1JdSyflysOK-g7KHhF8WzlLac87oD-bS4qISUHDq5Kn5dmewOOrvgWRhZRIP7HCIbaWl70N6gZZvpaE4S9JbtY7CzyYmZ4HN0w5wxsRyYDjE7QxG7YHFyfsM0qckRqOHJ6YnZYxpnb_4kOc-S8-FssugxUhtULOqcnhdPRj0lfHE-L4v7jx--Xn8qb7_cfL6-ui1NI_tcjiiGoYZWouBDJ2QrobJDJUYtAKDjemhbsL3VUugaW11B1fR2sI1uRjn0KC6LN6dcetPPGVNWO5cMTpP2GOakoCZHIxtoSPruJDU09RRxVPvodjoeFXC1kFFb9YCMWsgoXisiQ_6X51LzsEP7z_0XBQlenQSjDkpvIvnv7yihWbD10HWkuDkpkEZycBhVMg4XQo64ZWWD--9m3j9IMgTMGT39wCOmbZijp7krUKlSXN0tH2n5RyDo1jXfxG_GJcws</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Wu, Feng</creator><creator>Feng, Jin-Zhong</creator><creator>Qiu, Yi-Hua</creator><creator>Yu, Feng-Bin</creator><creator>Zhang, Jian-Zhong</creator><creator>Zhou, Wei</creator><creator>Yu, Feng</creator><creator>Wang, Guo-Kun</creator><creator>An, Li-Na</creator><creator>Ni, Fei-Hua</creator><creator>Wu, Hong</creator><creator>Zhao, Xian-Xian</creator><creator>Qin, Yong-Wen</creator><creator>Luo, He-De</creator><general>Elsevier Ireland Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130801</creationdate><title>Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats</title><author>Wu, Feng ; Feng, Jin-Zhong ; Qiu, Yi-Hua ; Yu, Feng-Bin ; Zhang, Jian-Zhong ; Zhou, Wei ; Yu, Feng ; Wang, Guo-Kun ; An, Li-Na ; Ni, Fei-Hua ; Wu, Hong ; Zhao, Xian-Xian ; Qin, Yong-Wen ; Luo, He-De</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c589t-fe3bb4168e30b7386812db23fa311170ab661d9da83a4e6a21259dbd5a5f8b9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>advanced glycation end products</topic><topic>aldehyde reductase</topic><topic>Aldehyde Reductase - metabolism</topic><topic>Animals</topic><topic>Aorta - innervation</topic><topic>Aorta - metabolism</topic><topic>Aorta - physiopathology</topic><topic>Aortic remodeling</topic><topic>arginine</topic><topic>atherosclerosis</topic><topic>Autonomic Denervation</topic><topic>Baroreflex - physiology</topic><topic>bioavailability</topic><topic>Cardiovascular</topic><topic>Cardiovascular Diseases - metabolism</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>collagen</topic><topic>Disease Models, Animal</topic><topic>Endothelial dysfunction</topic><topic>endothelial nitric oxide synthase</topic><topic>Endothelium, Vascular - innervation</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Inflammation</topic><topic>Lactoylglutathione Lyase - metabolism</topic><topic>Male</topic><topic>malondialdehyde</topic><topic>Mitochondria - metabolism</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>reactive oxygen species</topic><topic>Receptor for Advanced Glycation End Products</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Sinoaortic denervation</topic><topic>Vasculitis - metabolism</topic><topic>Vasculitis - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Feng</creatorcontrib><creatorcontrib>Feng, Jin-Zhong</creatorcontrib><creatorcontrib>Qiu, Yi-Hua</creatorcontrib><creatorcontrib>Yu, Feng-Bin</creatorcontrib><creatorcontrib>Zhang, Jian-Zhong</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Yu, Feng</creatorcontrib><creatorcontrib>Wang, Guo-Kun</creatorcontrib><creatorcontrib>An, Li-Na</creatorcontrib><creatorcontrib>Ni, Fei-Hua</creatorcontrib><creatorcontrib>Wu, Hong</creatorcontrib><creatorcontrib>Zhao, Xian-Xian</creatorcontrib><creatorcontrib>Qin, Yong-Wen</creatorcontrib><creatorcontrib>Luo, He-De</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Feng</au><au>Feng, Jin-Zhong</au><au>Qiu, Yi-Hua</au><au>Yu, Feng-Bin</au><au>Zhang, Jian-Zhong</au><au>Zhou, Wei</au><au>Yu, Feng</au><au>Wang, Guo-Kun</au><au>An, Li-Na</au><au>Ni, Fei-Hua</au><au>Wu, Hong</au><au>Zhao, Xian-Xian</au><au>Qin, Yong-Wen</au><au>Luo, He-De</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2013-08-01</date><risdate>2013</risdate><volume>229</volume><issue>2</issue><spage>287</spage><epage>294</epage><pages>287-294</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Abstract Objective The aim of present study was to test the hypothesis that activation of receptor for advanced glycation end products (RAGE) pathway contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated (SAD) rats. Methods and results Experiment 1 : 8 weeks after sinoaortic denervation, aortas were removed for measurement of AGE/RAGE pathway. Sinoaortic denervation in rats resulted in enhanced activity of aldose reductase, reduced activity of glyoxalase 1, accumulation of methylglyoxal and AGE, and upregulated expression of RAGE in aortas. Experiment 2 : 5 weeks after sinoaortic denervation, the rats received intraperitoneal injections of 500 μg soluble RAGE (sRAGE) daily for 3 weeks. Treatment of SAD rats with sRAGE attenuated aortic remodeling, marked by reduction in AW/length, wall thickness, proliferation of SMC, and collagen deposition, and improvement of endothelial function. Treatment of SAD rats with sRAGE abated aortic oxidative stress, marked by reduction in formation of malondialdehyde, reactive oxygen species, superoxide, peroxynitrite and 3-nitrotyrosine, and enhancement of ratio of GSH/GSSG. Treatment of SAD rats with sRAGE attenuated aortic mitochondrial dysfunction. Treatment of SAD rats with sRAGE suppressed aortic NFκB nuclear translocation and inflammation. Treatment of SAD rats with sRAGE restored aortic NO formation through upregulating eNOS and dimethylarginine dimethylaminohydrolase-2 and downregulating protein arginine methyltransferase-1. Conclusion Activated RAGE contributed to aortic remodeling and endothelial dysfunction in SAD rats, possibly via induction of oxidative stress and inflammation, impairment of mitochondrial function, and reduction in NO bioavailability.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>23880178</pmid><doi>10.1016/j.atherosclerosis.2013.04.033</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 2013-08, Vol.229 (2), p.287-294
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_1412558515
source MEDLINE; Elsevier ScienceDirect Journals
subjects advanced glycation end products
aldehyde reductase
Aldehyde Reductase - metabolism
Animals
Aorta - innervation
Aorta - metabolism
Aorta - physiopathology
Aortic remodeling
arginine
atherosclerosis
Autonomic Denervation
Baroreflex - physiology
bioavailability
Cardiovascular
Cardiovascular Diseases - metabolism
Cardiovascular Diseases - physiopathology
collagen
Disease Models, Animal
Endothelial dysfunction
endothelial nitric oxide synthase
Endothelium, Vascular - innervation
Endothelium, Vascular - metabolism
Endothelium, Vascular - physiopathology
Inflammation
Lactoylglutathione Lyase - metabolism
Male
malondialdehyde
Mitochondria - metabolism
Nitric oxide
Nitric Oxide - metabolism
Nitric Oxide Synthase Type III - metabolism
Oxidative stress
Oxidative Stress - physiology
Rats
Rats, Sprague-Dawley
reactive oxygen species
Receptor for Advanced Glycation End Products
Receptors, Immunologic - metabolism
Sinoaortic denervation
Vasculitis - metabolism
Vasculitis - physiopathology
title Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A07%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20receptor%20for%20advanced%20glycation%20end%20products%20contributes%20to%20aortic%20remodeling%20and%20endothelial%20dysfunction%20in%20sinoaortic%20denervated%20rats&rft.jtitle=Atherosclerosis&rft.au=Wu,%20Feng&rft.date=2013-08-01&rft.volume=229&rft.issue=2&rft.spage=287&rft.epage=294&rft.pages=287-294&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2013.04.033&rft_dat=%3Cproquest_cross%3E1412558515%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1412558515&rft_id=info:pmid/23880178&rft_els_id=1_s2_0_S002191501300275X&rfr_iscdi=true